Brief: Dynavax Technologies Q2 Net Income USD 3.431 Million
03/08/2023 21:05
Aug 03 (Reuters) - Dynavax Technologies Q2 operating expenses USD 63.654 million. * Q2 product revenues USD 56.44 million * Q2 operating income USD -3.405 million * Q2 pretax profit USD 4.207 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality